Strategy for Patient-Oriented Research (SPOR) Collaboration Grants due 14-Nov-17

Canadian Institutes of Health Research (CIHR) is pleased to announce the launch of the Strategy for Patient-Oriented Research (SPOR) Collaboration Grants.

The Strategy for Patient-Oriented Research (SPOR) Collaboration Grants are expected to catalyze patient-oriented research that aligns with the SPOR Capacity Development Framework and the SPOR Patient Engagement Framework by:

• Building capacity in Canada’s health system for patient-oriented research through projects conducted by teams comprised of researchers, patients, health care professionals and/or policy-makers; and,

• Increasing the number of new/early career investigators meaningfully involved in patient-oriented research by integrating them in patient-oriented research teams.
The deadline for applications is November 14, 2017. For more information, please see the funding opportunity page:

In order to assist in the establishment of collaborative teams or find funding partners, CIHR is providing a linkage tool to the community for this funding opportunity. This tool provides a web space for stakeholders to share contact information, areas of research interest, and expertise that may help form a collaborative team. It is not an obligatory step in the application process and does not confer any advantages for the applicants.


For all inquiries please contact:

CIHR Contact Center
Telephone: 613-954-1968
Toll Free: 1-888-603-4178


JOB POSTING: POGO Chief Executive Officer (Application due Sept-06)


The Board of Directors of POGO is seeking a new Chief Executive Officer (CEO) to succeed the long-serving, highly respected CEO. The new CEO, working closely with the Medical Director, will take POGO to new heights in leadership in the field of childhood cancer.

The ideal candidate is a strategic thinker and leader with experience in not-for-profit or publicly-funded organizations, and in mentoring and developing staff. Using a collaborative strategic framework and focusing on meeting the evolving needs of government, partners (current and future), clients and families, this leader will build on an excellent foundation. He/she should have experience in building collaborative and productive relationships with government and in securing funding from both government and alternative funding sources, and in supporting the implementation of a fundraising plan. The candidate’s strategic and analytical strengths will be critical in spearheading, together with the Board of Directors and Medical Director, the development of a new long-term strategic plan for POGO. The ideal candidate will bring a track record of leadership and administration both at the internal organization level and at a system level. Superior communication skills are of critical importance. A Master’s degree in a relevant discipline (or MBA) and knowledge of
healthcare are preferred.

A detailed briefing package about this opportunity can be found at

For more information about POGO, visit our website at

To apply, submit your resume and cover letter to the attention of Helen Craig, Executive Assistant to the Search Committee, at by September 6, 2017.

JOB POSTING: TRACE and CAR-T Cell Program Manager at BC Children’s Hospital Research Institute (apply by Aug-24)

A full description can be found at:

Job Summary :  The position is responsible for two projects with 50% responsibility to each.

50% of the position will be dedicated to acting as the TRACE Program Manager with responsibility for the management and logistical oversite of the Transplantation & Cell Therapy research program (TRACE) at BC Children’s Hospital (BCCH). This is a large multi-site, multi-project program involving both laboratory and clinically based research as well as biomarker development and cell therapy applications for patient care.

50% of the position will be dedicated to the Michael Cuccione Childhood Cancer Research Program (MC3RP) CAR-T cell project. The position will be responsible for BCCH participation in CAR-T cell clinical trials through the CureWorks consortium and the Cancer Immunotherapy Trials Network (CITN). The position will be responsible for development of a business plan, contract, Health Canada compliance, ensuring good clinical practice and Foundation for the Accreditation of Cellular Therapy (FACT) compliance with training of clinical and laboratory trials physicians and staff, and will work with the Michael Cuccicone Childhood Cancer research program clinical trials unit (CTU).


  • Post-graduate degree or equivalent professional designation if responsible for a research project otherwise Undergraduate degree if not responsible for a research project.
  • Society of Clinical Research Associates (SOCRA) certification is preferred.
  • 4 years or equivalent combination of education and experience if responsible for research project otherwise 6 years or equivalent combination of education and experience if not research work.
  • Experience managing large scale research projects; including writing protocols, developing SOPS, contracts, ethics, budgets, regulatory issues and performance of clinical trials, grant preparation, manuscript drafting.
  • Experience in clinical research and a research hospital environment. Excellent time management and project management skills.
  • Effective oral and written communication, interpersonal, and problem-solving skills. Ability to exercise appropriate tact, discretion, confidentiality, and good judgment in all matters.
  • Ability to work independently with appropriate initiative, as well as effectively with others in a team environment.
  • Ability to work accurately, and under pressure to meet deadlines.

MAKE IT STOP – a documentary about Ewing sarcoma by the Ewing Cancer Foundation of Canada – debuts scheduled for Richmond Hill ON (Sept 23), Labrador City (Sept 7), St John’s NL (Sept 17) and Fall River NS (Sept 23). Richmond Hill debut features live music by Tom Corrigan


You are cordially invited to celebrate the Debut of our most recent project. Through this important 45 minute documentary, we will share with you the history of Ewing sarcoma, stories of people affected and hear from doctors and researchers in Canada.
It will move, inspire and educate you!

September 23rd, 2017
Cosmo Music (Cosmopolitan Music Hall)
10 Via Renzo Drive
Richmond Hill, ON

Introduction: 2:00
Film screening will begin at 2:30
Refreshments and live music by Tom Corrigan

There is no charge for admission, however donations are greatly appreciated.  Please say you’ll come and share this Debut experience with us.  RSVP at by September 1st.

We are also hosting Debuts in the following areas; contact  if you would like to attend.

  • Labrador City- Sept. 7th
  • ST. John’s NL Sept. 17th
  • Fall River NS Sept. 23rd

Stay-tuned for funding and registration information for the C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop (04-Nov-2017, BC)

C17 “Next Generation of Early Phase Trials: Moving the Bar in Pediatric Oncology” educational workshop will be held on Saturday, 4 November 2017 in Vancouver, BC. The workshop is in response to the C17 DVL needs assessment that was completed last year; members from all C17 DVL sites and PROFYLE clinical site leads are encouraged to attend.

The workshop is a full day, pre-session workshop at the CCRA Canadian Cancer Research Conference. We hope that most attendees at our workshop will take the opportunity to attend the full conference as well.

The workshop will be designed to educate investigators on traditional models of early phase trials as well as newer approaches to drug development. We will also cover regulatory, ethical, advocacy and access aspects of early phase trials. The workshop will proved education, discussions, panels and time for questions.

If our fundraising is successful, our goal is to help provide some funding to C17 DVL participating centres to allow investigators and senior research staff to attend.

Registration will be live next week.

9th Annual Interaction Conference Sept 22-23 in Toronto: an integrated industry and academic conference targeted towards those who manage or direct projects related to oncology clinical trials (

On behalf of my fellow conference organizers, I would like to bring your attention to the ninth annual Interaction Conference – an Academic-Industry Cancer Trials meeting that will be held at the MaRS building in Toronto on September 22-23, 2017. The aim of this conference is to bring together cancer clinical trials staff from academia and pharma for a two day meeting. The meeting is being organized to cater to the needs of clinical trials staff, including project directors, project managers, CRAs, data coordinators, nurses, monitors, regulatory officers and administrators.

Important goals of this meeting are to foster closer cooperation and understanding between academia and pharma staff in the conduct of cancer studies.

Further information and a registration link can be found at

Please pass along to others who may be interested. Do not hesitate to contact us with any questions.

I look forward to seeing you in September.

Kind Regards,

Jasmine Grant, MEd, CCRP
Education Specialist Lead
Cancer Clinical Research Unit
Princess Margaret Cancer Centre
(416) 946-4501 x3465



BioCanRx Priority Funding Call LOI Due 01-Nov-2017

*PRIORITY FUNDING CALL: BioCanRx is pleased to announce that the next call for applications is now open in all of the Catalyst, Enabling, Clinical Trial, and Clinical, Social & Economic Impact (CSEI) programs. At this time, BioCanRx is placing highest priority on the intake of new applications for funding, proposing research activities that would be likely to add value to, facilitate the implementation of, or enhance the translation to clinic of, technologies within the existing BioCanRx portfolio of research investments. The projects contained within the BioCanRx research portfolio are found here. Of important note, new applications will be expected to speak very specifically to the value-add of their proposed research deliverables and the complementarity to support the successful development of BioCanRx technologies or research projects.

Funding timelines: Applicants should be aware that all projects must plan to be completed no later than March 31, 2020. Given this time constraint, it is unlikely that new clinical trial projects will be funded in this next call for proposals, unless the trial is of a small pilot scale AND the applicant(s) can convincingly demonstrate feasibility of completion of the study by March 31, 2020.

Application deadlines: Next LOI submission deadline will be 11:59 am EST on November 1, 2017 invited full applications are anticipated by mid-February (date TBD) for funding to commence by April 1, 2018.

Find application process and instructions here.

CCRA Interactive Reporting Tools

The interactive reporting tools have now been deployed to the CCRA website as a submenu under Initiatives – Canadian Cancer Research Survey. Please note that the link that I forwarded previously is now retired.

The reports are available in both official languages.



Note that there are a few remaining issues with the French. First, the Tableau Public interface (where the dashboards are embedded) is in English. Second, the All selection in the filter lists does not appear as ‘Tous’. And finally, the numbers are not appropriately formatted. I’m hoping that I will eventually be able to resolve these issues, but for now, the data itself is available in French.

Please let me know if you have any questions or concerns and thank you for your patience with this project.


Kimberly Badovinac, MA, MBA
Manager, Canadian Cancer Research Survey / Directrice, Enquête canadienne sur la recherche sur le cancer
Canadian Partnership Against Cancer / Partenariat canadien contre le cancer
1 University Avenue, Suite 300, Toronto ON M5J2P1
Ph / Tél : (416) 619-6265 /

NAIT August Newsletter Available Now – CTL019 now open

CTL019 CAR-T study now open at Sick Kids: Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients   see:

The August 2017 NAIT newsletter can be found HERE.

For more information on current and upcoming trials, please visit or send an email directly to

Solid Tumours: Dr. Daniel Morgenstern
Leukemia/Lymphoma: Dr. Jim Whitlock
CNS: Dr. Eric Bouffet
Patient Navigator: Karen Fung

BOOKMARK NAIT:  The current list of all open trials can be found on the NAIT Website at

HELPING FAMILIES NAVIGATE:  To assist patients and families with their transition, our Patient Navigator Program will collaborate with your team and the family to provide assistance with issues related to travel, accommodation, and navigating their way around the hospital and in the city. Furthermore, for patients living outside of Ontario, our Patient Navigator will assist physicians in completing an Out-of-Province Prior Approval Application to the Provincial Ministry of Health.

The vision of the New Agents and Innovative Therapy Program (NAIT) supports The Garron Cancer Centre and Sick Kids’ commitment to innovation and providing Canadian children and their families living with cancer with greater access to the best and newest treatment that will assist to improve clinical care.

CCO Call for Research Proposals – Analytics and Informatics  ** DEADLINE: Friday, August 18th by 5 pm (EDT)


Analytics and Informatics (A&I) at CCO is calling for research proposals by investigators to undertake research projects in the priority areas of capacity planning, implementation projects and population health projects.

I encourage you to apply for a research grant by completing the attached application form. Please refer to the attached announcement for further details, including eligibility criteria. Applications are due by 5 pm (EDT) to the CCO Research Office ( 

Please feel free to share this with any researcher in Ontario within your network who might be interested in applying for a research grant. I appreciate your assistance.


 Jason Garay BSc, BASc, MHSc
Vice President
Analytics & Informatics

Adjunct Professor, University of Toronto

CCO | Our future health built with care
620 University Ave., Toronto, ON M5G 2L7